Qualigen Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 0 | $1.54 | $1.54 | $1.54 |
Qualigen Therapeutics, Inc. Earnings Date And Information
Qualigen Therapeutics, Inc. last posted its earnings results on Monday, April 8th, 2024. The company reported $-0.47 earnings per share for the quarter, topping analysts' consensus estimates of $-0.52 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Qualigen Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.53 diluted earnings per share) and currently has a price-to-earnings ratio of -0.14. Qualigen Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Qualigen Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.19 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.34 | $0 | |||
| 12/29/2023 | Q4 2023 | -$0.47 | $0 | |||
| 11/14/2023 | Q3 2023 | -$0.92 | -$0.72 | 0.2 | $500,000 | $7.94 M |
| 08/14/2023 | Q2 2023 | -$0.69 | $1.60 M | $1.63 M | ||
| 05/15/2023 | Q1 2023 | -$0.83 | $1.61 M | |||
| 05/02/2023 | Q4 2022 | -$1.40 | -$2.03 | -0.63 | $1.39 M | |
| 11/14/2022 | Q3 2022 | -$0.97 | $1.62 M | $1.44 M | ||
| 08/15/2022 | Q2 2022 | -$1.13 | $1.20 M | $1.43 M | ||
| 05/13/2022 | Q1 2022 | -$1.70 | -$1.22 | 0.48 | $722,029 | |
| 03/31/2022 | Q4 2021 | -$1.70 | -$1.94 | -0.24 | $1.48 M | |
| 11/15/2021 | Q3 2021 | -$2.10 | -$0.98 | 1.12 | $1.34 M | $1.16 M |
| 08/16/2021 | Q2 2021 | -$1.84 | $1.70 M | $1.12 M | ||
| 05/14/2021 | Q1 2021 | -$1.60 | -$1.33 | 0.27 | $1.90 M | |
| 12/30/2020 | Q4 2020 | $3.03 | $1.11 M | |||
| 11/12/2020 | Q3 2020 | -$4.10 | $1.58 M | $837,714 | ||
| 08/14/2020 | Q2 2020 | -$21.24 | $904,067 | |||
| 05/01/2020 | Q1 2020 | -$2.98 | $1.46 M | |||
| 03/31/2020 | Q4 2019 | -$15.00 | -$10,588,244.32 | -10588229.32 | $-2,711,962 | |
| 11/13/2019 | Q3 2019 | -$0.64 | $1.20 M |
Qualigen Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Qualigen Therapeutics, Inc.'s earnings date?
Qualigen Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Qualigen Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Qualigen Therapeutics, Inc. (:QLGN) reported $-0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.52 by $0.05.
-
How can I listen to Qualigen Therapeutics, Inc.'s earnings conference call?
The conference call for Qualigen Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Qualigen Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Qualigen Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Qualigen Therapeutics, Inc. generate each year?
Qualigen Therapeutics, Inc. (:QLGN) has a recorded net income of $0. Qualigen Therapeutics, Inc. has generated $-2.53 earnings per share over the last four quarters.
-
What is Qualigen Therapeutics, Inc.'s price-to-earnings ratio?
Qualigen Therapeutics, Inc. (:QLGN) has a price-to-earnings ratio of -0.14 and price/earnings-to-growth ratio is -0.
